JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rorabaugh, B. R.
Right arrow Articles by Abel, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rorabaugh, B. R.
Right arrow Articles by Abel, P. W.

Vol. 299, Issue 3, 1086-1094, December 2001

Functional Calcitonin Gene-Related Peptide Subtype 2 Receptors in Porcine Coronary Arteries Are Identified as Calcitonin Gene-Related Peptide Subtype 1 Receptors by Radioligand Binding and Reverse Transcription-Polymerase Chain Reaction

Boyd R. Rorabaugh, Margaret A. Scofield, D. David Smith, William B. Jeffries and Peter W. Abel

Department of Pharmacology (B.R.R., M.A.S., W.B.J., P.W.A.) and Department of Biomedical Sciences (D.D.S.), Creighton University School of Medicine, Omaha, Nebraska

Calcitonin gene-related peptide (CGRP) receptors are classified into CGRP subtype 1 (CGRP1) and CGRP subtype 2 (CGRP2) based on the affinity of the antagonist, human alpha  (halpha )-CGRP8-37. halpha -CGRP8-37 antagonizes CGRP1 receptor-mediated responses with high affinity (KB < 100 nM) and antagonizes CGRP2 receptor-mediated responses with low affinity (KB > 1 µM). CGRP2 receptors have been previously reported to mediate relaxation of large porcine coronary arteries because this action is antagonized with low affinity by halpha -CGRP8-37. In the present study, we used reverse transcription-polymerase chain reaction, radioligand binding, and values from our previously reported isolated tissue experiments to compare the CGRP receptor in porcine coronary arteries with the porcine CGRP1 receptor stably expressed in human embryonic kidney (HEK) 293 cells. We identified calcitonin receptor-like receptor and receptor activity modifying protein 1 mRNA in coronary arteries. We also found that the ligand binding characteristics of the CGRP receptor in coronary arteries and the cloned CGRP1 receptor were highly similar. KI values for halpha -CGRP8-37 were 6.6 and 5.7 nM in porcine coronary arteries and the cloned CGRP1 receptor, respectively. The affinities (KB) of halpha -CGRP8-37 and five other antagonists were 22- to 707-fold lower in functional experiments measuring relaxation of coronary arteries than in radioligand binding experiments. Despite this difference in absolute affinity values, there was a high correlation of the rank order of affinity for the antagonists determined by the two methods. Thus halpha -CGRP8-37 antagonizes CGRP-induced relaxation of porcine coronary arteries with low affinity at the CGRP1 receptor. Taken together, these data do not support the existence of the CGRP2 receptor.


0022-3565/01/2993-1086$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Kawase, K. Okuda, and D. M. Burns
Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that respond differently to [Cys(Acm)2,7] calcitonin gene-related peptide and CGRP8-37
Am J Physiol Cell Physiol, October 1, 2005; 289(4): C811 - C818.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. L. Hay, G. Christopoulos, A. Christopoulos, D. R. Poyner, and P. M. Sexton
Pharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes
Mol. Pharmacol., May 1, 2005; 67(5): 1655 - 1665.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Chauhan, P.R.R. Gangula, S.J. Wimalawansa, and C. Yallampalli
Studies on the Effects of the N-Terminal Domain Antibodies of CalcitoninReceptor-Like Receptor and Receptor Activity-Modifying Protein 1 on CalcitoninGene-Related Peptide-Induced Vasorelaxation in Rat Uterine Artery
Biol Reprod, June 1, 2004; 70(6): 1658 - 1663.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Yallampalli, S.B. Kondapaka, P. Lanlua, S.J. Wimalawansa, and P.R.R. Gangula
Female Sex Steroid Hormones and Pregnancy Regulate Receptors for Calcitonin Gene-Related Peptide in Rat Mesenteric Arteries, but Not in Aorta
Biol Reprod, April 1, 2004; 70(4): 1055 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P.R.R. Gangula, C. Thota, S.J. Wimalawansa, R.D. Bukoski, and C. Yallampalli
Mechanisms Involved in Calcitonin Gene-Related Peptide-Induced Relaxation in Pregnant Rat Uterine Artery
Biol Reprod, November 1, 2003; 69(5): 1635 - 1641.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Hasbak, O. S. Opgaard, K. Eskesen, S. Schifter, H. Arendrup, J. Longmore, and L. Edvinsson
Investigation of CGRP Receptors and Peptide Pharmacology in Human Coronary Arteries. Characterization with a Nonpeptide Antagonist
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 326 - 333.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P. Lanlua, R.D. Bukoski, S.J. Wimalawansa, and C. Yallampalli
Effects of Pregnancy and Female Sex Steroid Hormones on Calcitonin Gene-Related Peptide Content of Mesenteric Artery in Rats
Biol Reprod, November 1, 2002; 67(5): 1430 - 1434.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. R. Poyner, P. M. Sexton, I. Marshall, D. M. Smith, R. Quirion, W. Born, R. Muff, J. A. Fischer, and S. M. Foord
International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors
Pharmacol. Rev., June 1, 2002; 54(2): 233 - 246.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.